Taylor & Francis
Expert Review of Respiratory Medicine
,  volume 19 ,  issue 4 ,  pages 389-397

Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study

Ioannis Tomos 1
, 
Ioannis Grigoropoulos 2
, 
Chrysavgi Kosti 1
, 
Serafeim Chrysikos 1
, 
Antonia Digalaki 1
, 
Konstantinos Thomas 2
, 
Georgios Hillas 1
, 
Pinelopi Kazakou 2
, 
Anastasia Antoniadou 2
, 
Dimitra Kavatha 2
, 
Katerina Dimakou 1
1
 
‘SOTIRIA’ Chest Diseases Hospital of Athens
2
 
Publication type: Journal Article
Publication date: 2025-03-04
Taylor & Francis
wos Q2
SJR: —
CiteScore: —
Impact factor: 2.7
ISSN: 17476348, 17476356
Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
0
Share
Cite this
GOST |
Cite this
GOST Copy
Tomos I. et al. Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study // Expert Review of Respiratory Medicine. 2025. Vol. 19. No. 4. pp. 389-397.
GOST all authors (up to 50) Copy
Tomos I., Grigoropoulos I., Kosti C., Chrysikos S., Digalaki A., Thomas K., Hillas G., Kazakou P., Antoniadou A., Kavatha D., Dimakou K. Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study // Expert Review of Respiratory Medicine. 2025. Vol. 19. No. 4. pp. 389-397.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1080/17476348.2025.2473486
UR - https://www.tandfonline.com/doi/full/10.1080/17476348.2025.2473486
TI - Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study
T2 - Expert Review of Respiratory Medicine
AU - Tomos, Ioannis
AU - Grigoropoulos, Ioannis
AU - Kosti, Chrysavgi
AU - Chrysikos, Serafeim
AU - Digalaki, Antonia
AU - Thomas, Konstantinos
AU - Hillas, Georgios
AU - Kazakou, Pinelopi
AU - Antoniadou, Anastasia
AU - Kavatha, Dimitra
AU - Dimakou, Katerina
PY - 2025
DA - 2025/03/04
PB - Taylor & Francis
SP - 389-397
IS - 4
VL - 19
SN - 1747-6348
SN - 1747-6356
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Tomos,
author = {Ioannis Tomos and Ioannis Grigoropoulos and Chrysavgi Kosti and Serafeim Chrysikos and Antonia Digalaki and Konstantinos Thomas and Georgios Hillas and Pinelopi Kazakou and Anastasia Antoniadou and Dimitra Kavatha and Katerina Dimakou},
title = {Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study},
journal = {Expert Review of Respiratory Medicine},
year = {2025},
volume = {19},
publisher = {Taylor & Francis},
month = {mar},
url = {https://www.tandfonline.com/doi/full/10.1080/17476348.2025.2473486},
number = {4},
pages = {389--397},
doi = {10.1080/17476348.2025.2473486}
}
MLA
Cite this
MLA Copy
Tomos, Ioannis, et al. “Comparison of effectiveness and safety between baricitinib and tocilizumab in severe COVID-19: a retrospective study.” Expert Review of Respiratory Medicine, vol. 19, no. 4, Mar. 2025, pp. 389-397. https://www.tandfonline.com/doi/full/10.1080/17476348.2025.2473486.